Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors
Ended Project Grant Awarded Last action
- Award ID
- R44CA250646
- Recipient
-
7 Hills Pharma Inc. UEI CJJ6DE7APKY6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,000,000
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Texas, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $1,015,591 | |
| Original award | $984,409 |
Quick answers
Who received award R44CA250646?
R44CA250646 was awarded to 7 Hills Pharma Inc. by National Cancer Institute (National Institutes of Health) on September 11, 2020.
How much is award R44CA250646 worth?
$2,000,000 has been obligated on R44CA250646.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award